|
1
|
Giatromanolaki A, Sivridis E, Athanassou
N, Zois E, Thorpe PE, Brekken RA, Gatter KC, Harris AL, Koukourakis
IM and Koukourakis MI: The angiogenic pathway ‘vascular endothelial
growth factor/flk-1(KDR)-receptor’ in rheumatoid arthritis and
osteoarthritis. J Pathol. 194:101–108. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gerber HP, McMurtrey A, Kowalski J, Yan M,
Keyt BA, Dixit V and Ferrara N: Vascular endothelial growth factor
regulates endothelial cell survival through the
phosphatidylinositol 3′-kinase/Akt signal transduction pathway:
Requirement for Flk-1/KDR activation. J Biol Chem. 273:30336–30343.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Deuse T, Peter C, Fedak PW, Doyle T,
Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC,
Robbins RC and Schrepfer S: Hepatocyte growth factor or vascular
endothelial growth factor gene transfer maximizes mesenchymal stem
cell-based myocardial salvage after acute myocardial infarction.
Circulation. 120(Suppl 11): S247–S254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soeki T, Tamura Y, Shinohara H, Tanaka H,
Bando K and Fukuda N: Serial changes in serum VEGF and HGF in
patients with acute myocardial infarction. Cardiology. 93:168–174.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ogawa H, Suefuji H, Soejima H, Nishiyama
K, Misumi K, Takazoe K, Miyamoto S, Kajiwara I, Sumida H, Sakamoto
T, et al: Increased blood vascular endothelial growth factor levels
in patients with acute myocardial infarction. Cardiology. 93:93–99.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee KW, Lip GY and Blann AD: Plasma
angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2 and
vascular endothelial growth factor levels in acute coronary
syndromes. Circulation. 110:2355–2360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Soeki T, Tamura Y, Shinohara H, Sakabe K,
Onose Y and Fukuda N: Serum hepatocyte growth factor predicts
ventricular remodeling following myocardial infarction. Circ J.
66:1003–1007. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hagikura K, Fukuda N, Yokoyama S, Yuxin L,
Kusumi Y, Matsumoto T, Ikeda Y, Kunimoto S, Takayama T, Jumabay M,
et al: Low invasive angiogenic therapy for myocardial infarction by
retrograde transplantation of mononuclear cells expressing the VEGF
gene. Int J Cardiol. 142:56–64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye L, Zhang W, Su LP, Haider HK, Poh KK,
Galupo MJ, Songco G, Ge RW, Tan HC and Sim EK: Nanoparticle based
delivery of hypoxia-regulated VEGF transgene system combined with
myoblast engraftment for myocardial repair. Biomaterials.
32:2424–2431. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yin R, Feng J, Chen D and Wu H: Serum
levels of vascular endothelial growth factor in patients with
anginapectoris and acute myocardial infarct. Chin Med Sci J.
15:205–209. 2000.PubMed/NCBI
|
|
11
|
Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S,
Arakawa H, Fujikawa H, Katsuki T and Shimada K: Expression of
vascular endothelial growth factor in patients with acute
myocardial infarct. J Am Coll Cardiol. 35:968–973. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsudaira K, Maeda K, Okumura N,
Yoshikawa D, Morita Y, Mitsuhashi H, Ishii H, Kondo T and Murohara
T: Nagoya Acute Myocardial Infarction Study (NAMIS) Group: Impact
of low levels of vascular endothelial growth factor after
myocardial infarction on 6-month clinical outcome: Results from the
Nagoya Acute Myocardial Infarction Study. Circ J. 76:1509–1516.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heeschen C, Dimmeler S, Hamm CW, Boersma
E, Zeiher AM and Simoons ML: CAPTURE (c7E3 Anti-Platelet Therapy in
Unstable REfractory angina) Investigators: Prognostic significance
of angiogenic growth factor serum levels in patients with acute
coronary syndromes. Circulation. 107:524–530. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Canadian Cardiovascular Society; American
Academy of Family Physicians; American College of Cardiology;
American Heart Association. Antman EM, Hand M, Armstrong PW, Bates
ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA,
Mullany CJ, et al: 2007 focused update of the ACC/AHA 2004
guidelines for the management of patients with ST-elevation
myocardial infarction: A report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines. J Am Coll Cardiol. 51:210–247. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Braunwald E, Antman EM, Beasley JW, Califf
RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J,
Levin TN, et al: American College of Cardiology; American Heart
Association. Committee on the Management of Patients With Unstable
Angina: ACC/AHA 2002 guideline update for the management of
patients with unstable angina and non-ST-segment elevation
myocardial infarction - summary article: A report of the American
College of Cardiology/American Heart Association task force on
practice guidelines (Committee on the Management of Patients with
Unstable Angina). J Am Coll Cardiol. 40:1366–1374. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Austen WG, Edwards JE, Frye RL, Gensini
GG, Gott VL, Griffith LS, McGoon DC, Murphy ML and Roe BB: A
reporting system on patients evaluated for coronary artery disease.
Report of the Ad Hoc Committee for Grading of Coronary Artery
Disease, Council on Cardiovascular Surgery, American Heart
Association. Circulation. 51(Suppl 4): 5–40. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poulsen SH: Clinical aspects of left
ventricular diastolic function assessed by Doppler echocardiography
following acute myocardial infarction. Dan Med Bull. 48:199–210.
2001.PubMed/NCBI
|
|
18
|
Bates DO, Hillman NJ, Williams B, Neal CR
and Pocock TM: Regulation of microvascular permeability by vascular
endothelial growth factors. J Anat. 200:581–597. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular
endothelial growth factor expression in gastric carcinoma. Cancer.
77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoberg M, Schmidt EL, Tuerk M, Stark V,
Aicher WK and Rudert M: Induction of endostatin expression in
meniscal fibrochondrocytes by co-culture with endothelial cells.
Arch Orthop Trauma Surg. 129:1137–1143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sluimer JC, Gasc JS, van Wanroij JL,
Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den
Akker LH, Corvol P, Wouters BG, et al: Hypexia, hypoxia-inducible
transcription factor, and macrophages in human atherosclerotic
plaques are correlated with intraplaque angiogenesis. J Am Coll
Cardial. 51:1258–1265. 2008. View Article : Google Scholar
|
|
22
|
Mao RM, Du ZB, Gao WM, Mi L and Zhu BL:
Time-dependent expression of vascular endothelial growth factor
after acute myocardial ischemia in rats. Fa Yi Xue Za Zhi.
28:179–184. 2012.(In Chinese). PubMed/NCBI
|
|
23
|
Wang Z and Si LY: Hypoxia-inducible
factor-1α and vascular endothelial growth factor in the
cardioprotective effects of intermittent hypoxia in rats. Ups J Med
Sci. 118:65–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Devaux Y, Vausort M, Azuaje F, Vaillant M,
Lair ML, Gayat E, Lassus J, Ng LL, Kelly D, Wagner DR and Squire
IB: Low levels of vascular endothelial growth factor B predict left
ventricular remodeling after acute myocardial infarction. J Card
Fail. 18:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zentilin L, Puligadda U, Lionetti V,
Zacchigna S, Collesi C, Pattarini L, Ruozi G, Camporesi S, Sinagra
G, Pepe M, et al: Cardiomyocyte VEGFR-1 activation by VEGF-B
induces compensatory hypertrophy and preserves cardiac function
after myocardial infarction. FASEB J. 24:1467–1478. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferrara N, Gerber HP and LeCouter J: The
biology of VEGF and its receptors. Nat Med. 9:669–676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gruchala M, Roy H, Bhardwaj S and
Ylä-Herttuala S: Gene therapy for cardiovascular diseases. Curr
Pharm Des. 10:407–423. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ratner M: Genentech discloses safety
concerns over Avastin. Nat Biotechnol. 22:11982004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shimokawahara H, Jougasaki M, Setoguchi M,
Ichiki T, Sonoda M, Nuruki N, Nakashima H, Murohara T and Tsubouchi
H: Relationship between vascular endothelial growth factor and left
ventricular dimension in patients with acute myocardial infarction.
J Cardiol. 64:360–365. 2014. View Article : Google Scholar : PubMed/NCBI
|
